In this review, we summarized the literatures on the role of the apelin–APJ system in diabetes and obesity, and we hope for further research that will establish their role as a new diagnostic marker or therapeutic agent in diabetes and obesity. This evidence concerns the gene APLNR and obesity due to melanocortin 4 receptor deficiency.